SCHEMBL29119447

SCHEMBL29119447

CCN1CCc2ccc(NC(C)=O)cc2CC1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.48
TLR9 Q9NR96 1/20 0.48
ACLY P53396 1/20 0.47
CYP1A2 P05177 1/20 0.46
ADRA2A P08913 1/20 0.46
MAOA P21397 1/20 0.46
SLC6A2 P23975 1/20 0.46
HTR2C P28335 1/20 0.46
SLC6A4 P31645 1/20 0.46
HTR2B P41595 1/20 0.46
BAZ2B Q9UIF8 1/20 0.45
HTR1A P08908 2/20 0.44
HTR2A P28223 1/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
GAA P10253 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2632813 0.81 ALDH1A1 (0.52) HSP90AA1TLR9BAZ2BRAB9ANPC1
SCHEMBL29119496 0.80 MLNR (0.51) ACLYCYP1A2ADRA2AMAOASLC6A2
SCHEMBL4591071 0.76 NPC1 (0.53) HSP90AA1TLR9ACLYCYP1A2ADRA2A
SCHEMBL29860127 0.75 ATAD2 (0.49) HTR1AHTR2ARAB9ANPC1KDM4E
SCHEMBL29119500 0.75 ATAD2 (0.49) HTR1AHTR2ARAB9ANPC1KDM4E
SCHEMBL29119509 0.75 TP53 (0.42) HSP90AA1KDM4EALDH1A1L3MBTL1MAPT
SCHEMBL11813937 0.74 RAB9A (0.53) BAZ2BRAB9AKDM4EALDH1A1L3MBTL1
SCHEMBL2248318 0.74 ACLY (0.53) ACLYCYP1A2ADRA2AMAOASLC6A2
SCHEMBL885867 0.73 DRD1 (0.54) CYP1A2KDM4EALDH1A1L3MBTL1GAA
SCHEMBL14067273 0.73 ALDH1A1 (0.54) CYP1A2ADRA2AMAOASLC6A2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116888127-A Tri-fused ring HPK1 inhibitor and application thereof 轩竹生物科技股份有限公司 2023-10-13 CN disclosed
WO-2022188823-A1 TRICYCLIC HPK1 INHIBITOR AND USE THEREOF 山东轩竹医药科技有限公司 2022-09-15 WO disclosed